• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

New strategy against pancteato-biliary carcinoma using NK4, a four-kringle antagonist of hepatocyte growth factor

Research Project

Project/Area Number 10470259
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionKyushu University

Principal Investigator

TANAKA Masao  Kyushu University, Department of surgery and oncology, Professor, 大学院・医学研究院, 教授 (30163570)

Co-Investigator(Kenkyū-buntansha) UCHIYAMA Akihiko  Kyushu University, Assistant professor, 医学部・附属病院, 助手 (20294936)
MORISAKI Takashi  Kyushu University, Assistant professor, 大学院・医学研究院, 助手 (90291517)
MIZUMOTO Kazuhiro  Kyushu University, Assistant professor, 医学部・附属病院, 助手 (90253418)
NAKAMURA Toshikazu  Osaka University, Graduate school of medicine, Professor, 大学院, 教授 (00049397)
SHIMURA Hideo  Fukuoka University, Department of surgery, Associate professor, 医学部, 助教授 (80178996)
小川 尚洋  九州大学, 医学部, 助手 (90294933)
Project Period (FY) 1998 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥12,500,000 (Direct Cost: ¥12,500,000)
Fiscal Year 2000: ¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 1999: ¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 1998: ¥6,000,000 (Direct Cost: ¥6,000,000)
KeywordsHGF / Cancer / Pancreas / Biliary tract / HGF antagonist / NK4 / Invasion / Metastasis / Dissemination
Research Abstract

Because of the highly aggressive behaviour, i.e., invasive, disseminative, and metastatic properties, the outcome for patients with pancreatic cancer is morbid. A better understanding and interference with the malignant behavior of pancreatic cancer may provide new directions for treatment. We report here the induction of highly motile and invasive properties in human pancreatic cancer cells by hepatocyte growth factor (HGF) and blockage of these properties by NK4, a newly identified antagonist for HGF.In all of 8 human pancreatic cancer cell lines we used (AsPC-1, BxPC-3, H-48N, KP-1N, KP-2, KP-3, MIA PaCa-2 and SUIT-2 cells), the c-Met/HGF receptor was expressed at varying levels. Although weak mitogenic activity of HGF was seen only in SUIT-2 and KP-3 cells, HGF strongly stimulated migration and invasion of these pancreatic cancer cells, except for BxPC-3 and MIA PaCa-2 cells. In contrast, migration and invasion potently induced by HGF in KP-1N, KP-3, and SUIT-2 cells were inhibited by NK4. The invasion of SUIT-2 cells was also potently stimulated with the influence of co-cultured pancreatic fibroblasts and by ascitic fluid obtained after pancreatic cancer resection, however, invasiveness of the cancer cells in such conditions was practically abolished by NK4. Consistently, the ascitic fluid in patients who had undergone pancreatic cancer surgery contained high levels of HGF.Furthermore, Adenovirus harboring NK4 (Ad-NK4) significantly inhibited the growth of transplanted tumors in nude mice. The tumor reduction induced by Ad-NK4 was associated with a decreased number of blood vessels surrounding the tumors.
These findings mean that HGF is probably involved in invasion, dissemination, and metastasis of pancreatic cancer, particularly through tumour-stromal interaction and after resection of the pancreatic cancer. NK4, an effective antagonist of HGF, may prove to have the potential for anti-invasion/metastasis.

Report

(4 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Date K, et al: "Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor"Oncogene. 17(23). 3045-54 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Matumoto K et al.: "Cooperative interaction between alpha-and beta-chains of hepatocyte growth factor on c-MET receptor confers ligand-induced receptor"J Biol Chem. 273(36). 22913-20 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kuba K, et al.: "HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice"Cancer Res. 60(23). 6737-43 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kuba K, et al.: "Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human micronascular endothelial cells"Biochem Biophys Res Commun. 279(3). 846-52 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Maehara N, et al.: "NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells"Br J Cancer. (in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Machara N et al: "NK4, a four kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells"Br J Cancer. (in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kuba K et al.: "Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells"Biochem Biophys Res Commun. 279(3). 846-52 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kuba K et al.: "HGF/NK4, a four kringle antagonist of hepatocyte growth factor, is an angigenesis inhibitor that suppresses tumor growth and metastasis in mice"Cancer Res. 60(23). 6737-43 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Date K et al.: "Inhibition of tumor growth and invasion by a four kringle antagonist (HGF/NK4) for hepatocyte growth factor"Oncogene. 17(23). 3045-54 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Matsumoto K et al.: "Cooperative interaction between alph-and beta-chains of hepatocyte growth factor on c-MET receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responces"J Biol Chem. 273(36). 22913-20 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kuba K, et al.: "HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mide"Cancer Res. 60(23). 6737-43 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Kuba K, et al.: "Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human micronascular endothelial cells"Biochem Biophys Res Commun. 279(3). 846-52 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Maehara N, et al.: "NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells"Br J Cancer. (in press). (2001)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi